Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

21
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
21
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

14
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
14
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

26
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
26
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

19
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
19
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

14
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
14
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

22
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
22

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal and fetal outcomes of lipid-lowering drug use in pregnancy: A Czech nationwide study.

Journal of clinical lipidology·2026
Same author

Patient perspective on the management of hypertension in 7 European countries: insights from a survey of 4001 patients.

Polish archives of internal medicine·2026
Same author

The Co-Occurrence of Pertrochanteric Fracture and Acute Coronary Syndrome in a Geriatric Patient: A Case Report and Review of the Literature.

Journal of cardiovascular development and disease·2026
Same author

MELAS Syndrome Presenting with Hypertrophic Cardiomyopathy and Advanced Heart Failure: A Multisystem Diagnostic Challenge.

Journal of clinical medicine·2026
Same author

Interdisciplinary recommendations for thrombophilia testing.

Casopis lekaru ceskych·2026
Same author

Improvement of severe hypertriglyceridemia in atypical subtype 4 partial lipodystrophy with volanesorsen.

Journal of clinical lipidology·2026

Related Experiment Video

Updated: Aug 6, 2025

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

3.8K

News in cardiology.

Jan Václavík

    Vnitrni Lekarstvi
    |March 17, 2023
    PubMed
    Summary

    Key 2022 cardiology advances include polypill use post-myocardial infarction and dapagliflozin for heart failure. Early hypertension treatment in pregnancy and optimized heart failure drug titration also show significant benefits.

    Area of Science:

    • Cardiology
    • Internal Medicine
    • Cardiovascular Research

    Background:

    • Recent advancements in cardiology significantly impact clinical practice for internists and cardiologists.
    • The year 2022 brought several practice-changing studies in cardiovascular medicine.

    Purpose of the Study:

    • To summarize pivotal cardiology research from 2022.
    • To highlight findings relevant to everyday clinical decision-making.

    Main Methods:

    • Review of major clinical trials published in 2022.
    • Analysis of studies focusing on myocardial infarction, hypertension in pregnancy, heart failure, and perioperative care.

    Main Results:

    • Polypill administration post-myocardial infarction (SECURE study) proved effective.
    Keywords:
    SGLT2arterial hypertensioncardiologyheart failurehypertension during pregnancymyocardial infarctionupdate

    More Related Videos

    Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
    07:20

    Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

    Published on: February 10, 2023

    1.3K
    In Silico Clinical Trials for Cardiovascular Disease
    09:09

    In Silico Clinical Trials for Cardiovascular Disease

    Published on: May 27, 2022

    1.8K

    Related Experiment Videos

    Last Updated: Aug 6, 2025

    Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
    07:41

    Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

    Published on: February 8, 2022

    3.8K
    Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
    07:20

    Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

    Published on: February 10, 2023

    1.3K
    In Silico Clinical Trials for Cardiovascular Disease
    09:09

    In Silico Clinical Trials for Cardiovascular Disease

    Published on: May 27, 2022

    1.8K
  • Early hypertension pharmacotherapy in pregnant women (CHAP study) and dapagliflozin for heart failure (DELIVER study) demonstrated efficacy.
  • For heart failure patients, sodium restriction is unnecessary (SODIUM-HF study), and rapid up-titration of guideline-recommended drugs is beneficial (STRONG-HF study).
  • Antihypertensive timing (TIME study) and choice between hydrochlorothiazide and chlortalidone (DCP study) showed no significant differences in cardiovascular events.
  • Measuring highly sensitive troponin perioperatively aids in detecting myocardial infarction in high-risk surgical patients.
  • Specific blood pressure and oxygenation targets post-resuscitation do not alter treatment outcomes.

    • Conclusions:

    • Several 2022 studies offer new evidence-based strategies for managing cardiovascular conditions.
    • These findings provide practical guidance for optimizing patient care in cardiology and internal medicine.